Clinical trial
Randomized Double Blind Placebo Control Study in Patients with Schizophrenia
NCT01602029
Study timeline
Study start (unknown)2010-08-01Date precision: month
Registry last updated2024-12-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Psychosis Not Otherwise Specifiedunresolved
Schizophreniform Disorderunresolved
Interventions
Sponsors & collaborators
Pakistan Institute of Living and Learninglead sponsor
Stanley Medical Research Institutecollaborator
Dow University of Health Sciencescollaborator
Abbasi Shaheed Hospitalcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01602029 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.